Infective endocarditis as a mid-term complication after transcatheter aortic valve implantation: case report and literature review
Language English Country United States Media print-electronic
Document type Case Reports, Journal Article, Review
PubMed
24550078
DOI
10.1002/ccd.25454
Knihovny.cz E-resources
- Keywords
- follow-up, infective endocarditis, transcatheter aortic valve implantation,
- MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- Aortic Valve Stenosis diagnosis therapy MeSH
- Endocarditis, Bacterial diagnosis drug therapy microbiology MeSH
- Time Factors MeSH
- Heart Valve Prosthesis Implantation adverse effects instrumentation MeSH
- Echocardiography, Transesophageal MeSH
- Prosthesis-Related Infections diagnosis drug therapy microbiology MeSH
- Humans MeSH
- Tomography, X-Ray Computed MeSH
- Prosthesis Design MeSH
- Aged, 80 and over MeSH
- Heart Valve Prosthesis adverse effects MeSH
- Cardiac Catheterization adverse effects instrumentation MeSH
- Streptococcal Infections diagnosis drug therapy microbiology MeSH
- Viridans Streptococci isolation & purification MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Review MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
Few cases of infective endocarditis (IE) as a complication of percutaneous transcatheter aortic valve implantation (TAVI) have been reported. Here, we present a case of IE caused by Streptococcus viridans that occurred 6 months after TAVI with the corevalve revalving system. The patient was successfully treated with antibiotics and was asymptomatic during the 2 years after IE. We also present a review of the literature, including 15 published cases of IE after TAVI.
References provided by Crossref.org
